BI
BMY icon

Binnacle Investments’s Bristol-Myers Squibb BMY Stock Holding History

Binnacle Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$82.1K Buy
1,820
+19
+1% +$887 0.05% 123
2025
Q2 		$83.4K Buy
1,801
+262
+17% +$12.9K 0.05% 109
2025
Q1 		$93.9K Buy
+1,539
New +$89.7K 0.07% 98

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Binnacle Investments's BMY Position: Q3 2025 in Review

Binnacle Investments increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q3 2025, buying an estimated $887 and bringing the position to 1,820 shares worth $82.1K. The position accounts for 0.05% of the portfolio, ranked #123.

Binnacle Investments first reported a position in BMY in Q1 2025 and has held it in 3 quarters since. The position peaked at $93.9K in Q1 2025. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Binnacle Investments held 1,820 shares of Bristol-Myers Squibb worth $82.1K as of Q3 2025.
  • Binnacle Investments bought 19 Bristol-Myers Squibb shares in Q3 2025, an estimated $887.
  • Bristol-Myers Squibb made up 0.05% of Binnacle Investments's portfolio in Q3 2025, its #123 holding.
  • Binnacle Investments first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 3 quarters since.
  • Binnacle Investments's Bristol-Myers Squibb position peaked at $93.9K in Q1 2025.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.